Atkinson, T. M., Li, Y., Coffey, C. W., Sit, L., Shaw, M., Lavene, D., et al. (2012). Reliability of adverse symptom event reporting by clinicians. Quality of Life Research, 21, 1159–1164. https://doi.org/10.1007/s11136-011-0031-4.
Article
PubMed
Google Scholar
Flores, L. T., Bennett, A. V., Law, E. B., Hajj, C., Griffith, M. P., & Goodman, K. A. (2012). Patient-reported outcomes vs. clinician symptom reporting during chemoradiation for rectal cancer. Gastrointestinal Cancer Research, 5, 119–124.
PubMed
Google Scholar
Basch, E., Jia, X., Heller, G., Barz, A., Sit, L., Fruscione, M., et al. (2009). Adverse symptom event reporting by patients vs clinicians: Relationships with clinical outcomes. Journal of the National Cancer Institute, 101, 1624–1632. https://doi.org/10.1093/jnci/djp386.
Article
PubMed
PubMed Central
Google Scholar
Atkinson, T. M., Ryan, S. J., Bennett, A. V., Stover, A. M., Saracino, R. M., Rogak, L. J., et al. (2016). The association between clinician-based common terminology criteria for adverse events (CTCAE) and patient-reported outcomes (PRO): A systematic review. Supportive Care in Cancer, 24, 3669–3676. https://doi.org/10.1007/s00520-016-3297-9.
Article
PubMed
PubMed Central
Google Scholar
Denis, F., Basch, E. M., Lethrosne, C., Pourel, N., Molinier, O., Pointreau, Y., et al. (2018). Randomized trial comparing a web-mediated follow-up via patient-reported outcomes (PRO) vs. routine surveillance in lung cancer patients: final results. Journal of Clinical Oncology, 36, 6500–6500. https://doi.org/10.1200/JCO.2018.36.15_suppl.6500.
Article
Google Scholar
Basch, E., Deal, A. M., Dueck, A. C., Scher, H. I., Kris, M. G., Hudis, C., & Schrag, D. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Journal of the American Medical Association, 318, 197–198. https://doi.org/10.1001/jama.2017.7156.
Article
PubMed
Google Scholar
Fromme, E. K., Eilers, K. M., Mori, M., Hsieh, Y. C., & Beer, T. M. (2004). How accurate is clinician reporting of chemotherapy adverse effects? A comparison with patient-reported symptoms from the quality-of-life questionnaire C30. Journal of Clinical Oncology, 22, 3485–3490. https://doi.org/10.1200/jco.2004.03.025.
Article
PubMed
Google Scholar
Basch, E., Wood, W. A., Schrag, D., Sima, C. S., Shaw, M., Rogak, L. J., et al. (2016). Feasibility and clinical impact of sharing patient-reported symptom toxicities and performance status with clinical investigators during a phase 2 cancer treatment trial. Clinical Trials, 13, 331–337. https://doi.org/10.1177/1740774515615540.
Article
PubMed
Google Scholar
Basch, E., Pugh, S. L., Dueck, A. C., Mitchell, S. A., Berk, L., Fogh, S., et al. (2017). Feasibility of patient reporting of symptomatic adverse events via the patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) in a chemoradiotherapy cooperative group multicenter clinical trial. International Journal of Radiation Oncology, Biology, Physics, 98, 409–418. https://doi.org/10.1016/j.ijrobp.2017.02.002.
Article
PubMed
PubMed Central
Google Scholar
Kluetz, P. G., Slagle, A., Papadopoulos, E. J., Johnson, L. L., Donoghue, M., Kwitkowski, V. E., et al. (2016). Focusing on core patient-reported outcomes in cancer clinical trials: Symptomatic adverse events, physical function, and disease-related symptoms. Journal of Clinical Cancer Research, 22, 1553–1558.
Article
CAS
Google Scholar
Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Dueck, A. C., et al. (2014). Development of the National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute, 106. https://doi.org/10.1093/jnci/dju244.
Basch, E., Reeve, B. B., Mitchell, S. A., Clauser, S. B., Minasian, L. M., Dueck, A. C., et al. (2014). Development of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of the National Cancer Institute, 106, dju244.
Article
Google Scholar
Dueck, A. C., Mendoza, T. R., Mitchell, S. A., Reeve, B. B., Castro, K. M., Rogak, L. J., et al. (2015). Validity and reliability of the US National Cancer Institute's Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Journal of the American Medical Association Oncology, 1, 1051–1059. https://doi.org/10.1001/jamaoncol.2015.2639.
Article
Google Scholar
Hay, J. L., Atkinson, T. M., Reeve, B. B., Mitchell, S. A., Mendoza, T. R., Willis, G., et al. (2014). Cognitive interviewing of the US National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Quality of Life Research, 23, 257–269.
Article
Google Scholar
Bæksted, C., Nissen, A., Pappot, H., Bidstrup, P. E., Mitchell, S. A., Basch, E., et al. (2016). Danish translation and linguistic validation of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Journal of Pain and Symptom Management, 52, 292–297.
Article
Google Scholar
Kirsch, M., Mitchell, S. A., Dobbels, F., Stussi, G., Basch, E., Halter, J. P., & De Geest, S. (2015). Linguistic and content validation of a German-language PRO-CTCAE-based patient-reported outcomes instrument to evaluate the late effect symptom experience after allogeneic hematopoietic stem cell transplantation. European Journal of Oncology Nursing, 19, 66–74.
Article
Google Scholar
Arnold, B., Mitchell, S. A., Lent, L., Mendoza, T. R., Rogak, L. J., Barragán, N. M., et al. (2016). Linguistic validation of the Spanish version of the National Cancer Institute’s patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE). Supportive Care in Cancer, 24, 2843–2851.
Article
Google Scholar
Yamaguchi, T., Iwase, S., Kuroda, Y., Yamamoto, D., Tsubota, Y., Goto, Y., et al. (2012). Introduction and current status of the development program for a Japanese version of the NCI PRO-CTCAE. Annals of Oncology, 23, xi100–xi101. https://doi.org/10.1016/S0923-7534(20)32256-0.
Article
Google Scholar
Wild, D., Grove, A., Martin, M., Eremenco, S., McElroy, S., Verjee-Lorenz, A., & Erikson, P. (2005). Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: Report of the ISPOR task force for translation and cultural adaptation. Value in Health, 8, 94–104.
Article
Google Scholar
Reeve, B. B., Mitchell, S. A., Dueck, A. C., Basch, E., Cella, D., Reilly, C. M., et al. (2014). Recommended patient-reported core set of symptoms to measure in adult cancer treatment trials. Journal of the National Cancer Institute, 106, dju129. https://doi.org/10.1093/jnci/dju129.
Article
PubMed
PubMed Central
Google Scholar
Willis, G. B. (2004). Cognitive interviewing: A tool for improving questionnaire design. California: Sage Publications.
Willis, G. B., Reeve, B. B, & Barofsky, I. (2004). The use of cognitive interviewing techniques in quality of life and patient-reported outcomes measurement. In Lipscomb, J., C.C. Gotay, C.C., and C. Snyder (Eds.), Outcomes assessment in cancer: findings and recommendations of the cancer outcomes measurement working group, pp. 610–622. Cambridge University Press.
Miyaji, T., Iioka, Y., Kuroda, Y., Yamamoto, D., Iwase, S., Goto, Y., et al. (2017). Japanese translation and linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Journal of Patient-Reported Outcomes, 1, 8.
Article
Google Scholar
Cho, J., Yoon, J., Kim, Y., Oh, D., Kim, S. J., Ahn, J., et al. (2019). Linguistic validation of the US National Cancer Institute’s Patient-Reported Outcomes Version of the Common Terminology Criteria for Adverse Events in Korean. Journal of Global Oncology, 5, 1–10.
Article
CAS
Google Scholar
Terwee, C., Roorda, L., De Vet, H., Dekker, J., Westhovens, R., Van Leeuwen, J., et al. (2014). Dutch–Flemish translation of 17 item banks from the patient-reported outcomes measurement information system (PROMIS). Quality of Life Research, 23, 1733–1741.
CAS
PubMed
Google Scholar
Sajobi, T. T., Brahmbatt, R., Lix, L. M., Zumbo, B. D., & Sawatzky, R. J. (2018). Scoping review of response shift methods: current reporting practices and recommendations. Quality of Life Research, 27, 1133–1146.
Article
Google Scholar
Schwartz, C. E., & Sprangers, M. A. (2000). Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research. Social Science and Medicine, 48, 1531–1548. https://doi.org/10.1016/s0277-9536(99)00047-7.
Article
Google Scholar
Chung, A. E., Shoenbill, K., Mitchell, S. A., Dueck, A. C., Schrag, D., Bruner, D. W., et al. (2019). Patient free text reporting of symptomatic adverse events in cancer clinical research using the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). Journal of the American Medical Informatics Association, 26, 276–285.
Article
Google Scholar
Kluetz, P. G., Chingos, D. T., Basch, E. M., & Mitchell, S. A. (2016). Patient-reported outcomes in cancer clinical trials: Measuring symptomatic adverse events with the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE). American Society of Clinical Oncology Educational Book, 36, 67–73.
Article
Google Scholar
Mendoza, T. R., Dueck, A. C., Bennett, A. V., Mitchell, S. A., Reeve, B. B., Atkinson, T. M., et al. (2017). Evaluation of different recall periods for the US National Cancer Institute’s PRO-CTCAE. Clinical Trials, 14, 255–263.
Article
Google Scholar
United States National Cancer Institute (2019) Patient-reported outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE™). https://healthcaredelivery.cancer.gov/pro-ctcae/. Accessed 2 Apr 2020
Google Scholar
Wilson, M. K., Collyar, D., Chingos, D. T., Friedlander, M., Ho, T. W., Karakasis, K., et al. (2015). Outcomes and endpoints in cancer trials: bridging the divide. The Lancet Oncology, 16, e43–e52.
Article
Google Scholar
Basch, E., Abernethy, A. P., Mullins, C. D., Reeve, B. B., Smith, M. L., Coons, S. J., et al. (2012). Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. Journal of Clinical Oncology, 30, 4249–4255.
Article
Google Scholar